In addition, it has been proposed that CD8+ T cells can provide pathogenesis directly, by exacerbating the CD4+ T cell-mediated disease, or by regulating the activity of myelin-specific CD4+ T cells in MS [9–12], even though all the relevant (self or non-self) antigen specificities have not been yet identified. This evidence concerns the gene CD8A and myeloid sarcoma.